Wednesday, August 07, 2013

Technical Breakout; Aethlon Medical (OTCQB: AEMD) Sets Record Trading Highs


Point Roberts, WA, New York, NY - August 7, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a technical trading alert for Aethlon Medical, Inc. (OTCQB: AEMD). The stock had a technical breakout and a significant 5 day run. Following breaking through its 52 week high of $.020, it traded up over 40% in yesterdays session to close at $0.27 on strong volume and momentum.

On July 18 th Zacks Small Cap Research issued an update entitled AEMD: Recent Progress Helps De-Risk Aethlon by Brian Marckx, CFA. The report included a pricing target for the stock that has since been surpassed.
Investors have reacted to a stream of positive news in the past several weeks including
FDA approval of an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the United States. The Hemopurifier ® is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
Additionally the company announced a contract from the Defense Advanced Research Projects Agency, or DARPA, including partners Battelle, NxStage Medical (NASDAQ: NXTM), that represents a four year $22.83 million deal to design, develop, test and validate an advanced, portable medical device.
The most recent update was an announcement that the European Patent Office has provided Aethlon with a Decision to Grant a Patent entitled "METHOD OF REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSIS” has taken the stock to a new technical trading pattern.
The European Patent will be assigned Patent No. 1624784 and has been referenced in European Patent Office Bulletin No. 13/29.
August 6 th close
Investorideas.com Newswire 5 day chart
Investorideas.com Newswire About Aethlon Medical (OTCQB: AEMD)
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under a 5-year contract with DARPA to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
Zacks research link:
http://finance.yahoo.com/news/aemd-recent-progress-helps-risk-110000781.html
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter   http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech and medical technology stocks:
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated by AEMD for news release distribution and content publishing: three thousand per month effective June 2013 http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 or 212-822-8842Source - www.Investorideas.com

Tuesday, August 06, 2013

Stem Cell Stock Alert: BioRestorative Therapies (OTCBB: BRTX) Receives Approval to Conduct Retrospective Safety Study on its Bulging/ Herniated Disc Procedure

JUPITER, Fla. - August 6, 2013 (Investorideas.com Newswire) BioRestorative Therapies Inc. ("BRT" or the "Company") (OTCQB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has received approval from the Western Institutional Review Board ("the Board") to complete a retrospective safety study on selected subjects previously treated by the Company's brtxDISC™ bulging and herniated disc procedure. The study is titled "Re-consenting and Follow-Up of Adults from a Retrospective Study Using Autologous Transplantation of Marrow Derived Mesenchymal Stem Cells to Degenerated Intervertebral Disc."

Study objectives are to determine the safety of subjects who received transplants of their own stem cells into their disc, using MRI and Quality of Life Questionnaires. The Board requires that all subjects must be able to consent for themselves to be enrolled in the study, which has been approved to take place at the Centeno-Schultz Clinic in Broomfield, Colorado.
The approval allows BRT to retrospectively collect and analyze clinical data on selected subjects who previously have been treated for bulging or herniated disc disease with the Company's novel brtxDISC™ procedure. These procedures were performed using BRT's proprietary therapeutic delivery device cannula system and its proprietary culture method isolating a selective population of mesenchymal stem cells. BRT expects to complete the study within a six-month period.
"This is a significant milestone in taking our brtxDISC™ procedure closer towards an FDA meeting to seek approval for the commencement of our clinical trial. We look forward to collecting this data with the ambition of meeting the safety requirements necessary for us to receive approval and start our trial," commented Mark Weinreb, Chief Executive Officer of BioRestorative Therapies. "Our goal is to compile and present the necessary data to the FDA with the goal of initiating a Phase I or Phase II clinical trial in the early part of next year."
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. ("BRT"), www.biorestorative.com, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, designed for patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives:
  • brtxDISC™ Program (Disc Implanted Stem Cells), a non-surgical treatment for bulging and herniated discs that addresses the gap between non-invasive and invasive back procedures. This research is still in the non-clinical, investigational stage.
  • ThermoStem® Program, a treatment for metabolic disorders (diabetes, heart disease, etc.) and obesity using brown fat stem cells. Initial non-clinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body.
  • brtx-C Cosmetic Program, based on the development of a human cellular extract that, per initial in vitro studies, when applied to human skin cells, appears to cause an increase in the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. Potential cosmetic uses are being explored with third parties.
The Company also offers plant stem cell-based facial creams and beauty products under the Stem Pearls® brand at www.stempearls.com.
This press release and the interview contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
Investor Contact:
Adam Holdsworth
ProActive Capital
646.862.4607
adamh@proactivecapital.com
Media Contact:
Sandra Lee
ProActive Capital
646.862.4608
slee@proactivecapital.com
Disclaimer /Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk.
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: BioRestorative has compensated Investoridea for a six month news program ( five thousand ) to be published on Investorideas.com newswire and syndication and social media partners.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Medical Technology Stock Trading Alert: Aethlon Medical (OTCQB: AEMD) Trades at 52-Week High

Point Roberts, WA, New York, NY - August 6, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a trading alert for Aethlon Medical, Inc. (OTCQB: AEMD). The stock closed Monday’s trading session at $0.1870, gaining 0.0270 or 16.88% on over 1.9 Million shares. The stock traded as high as $0.20, its 52- week high.

The stock made its first run in July when it announced FDA approval of an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the United States. The Hemopurifier ® is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
The next move was after news that Battelle, NxStage Medical (NASDAQ: NXTM), Inc. and Aethlon Medical (OTCQB: AEMD) won a contract from the Defense Advanced Research Projects Agency, or DARPA. The contract funded in phases and could be as large as $22.83 million and last as long as four years -- is for leading one of DARPA's DLT System Integration projects. The project calls for Battelle and key subcontractors, NxStage and Aethlon, to design, develop, test and validate an advanced, portable medical device that exhibits the technical innovation for which DARPA projects are known, and to coordinate integration of key technologies developed during the overall DLT program. This funding does not include human clinical trials that may be required prior to military use and/or United States Food and Drug Administration clearance for sepsis-treatment technologies.
Reaching these key milestones followed by news that that the European Patent Office has provided the Company with a Decision to Grant a Patent entitled "METHOD OF REMOVAL OF VIRUSES FROM BLOOD BY LECTIN AFFINITY HEMODIALYSIS” has taken the stock to a new technical trading pattern.
The European Patent will be assigned Patent No. 1624784 and has been referenced in European Patent Office Bulletin No. 13/29.
Investorideas.com Newswire About Aethlon Medical (OTCQB: AEMD)
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under a 5-year contract with DARPA to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech and medical technology stocks:
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated by AEMD for news release distribution and content publishing: three thousand per month effective June 2013 http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 or 212-822-8842
Source - www.Investorideas.com

Friday, August 02, 2013

Medical Technology Stock Trading Alert: Aethlon Medical (OTCQB: AEMD) Gains 21%

Point Roberts, WA, New York, NY - August 2, 2013 (Investorideas.com newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including biotech and medical technology stocks, issues a trading alert for Aethlon Medical, Inc. (OTCQB: AEMD), The stock is trading at 0.17, up 0.03 or 21.43% as of 2:25PM EDT on over 1.3 Million shares, with a high of $0.18.

In late July the company reported that Battelle, NxStage Medical (NASDAQ: NXTM), Inc. and Aethlon Medical (OTCQB: AEMD) won a contract from the Defense Advanced Research Projects Agency, or DARPA, to develop an innovative, new medical device that may save the lives of soldiers -- and civilians as well -- by treating sepsis.
The contract, funded in phases and could be as large as $22.83 million and last as long as four years -- is for leading one of DARPA's DLT System Integration projects. The project calls for Battelle and key subcontractors, NxStage and Aethlon, to design, develop, test and validate an advanced, portable medical device that exhibits the technical innovation for which DARPA projects are known, and to coordinate integration of key technologies developed during the overall DLT program. This funding does not include human clinical trials that may be required prior to military use and/or United States Food and Drug Administration clearance for sepsis-treatment technologies.
The company also reported in July FDA approval of an Investigational Device Exemption (IDE) that allows the Company to initiate human feasibility studies of the Aethlon Hemopurifier® in the United States. The Hemopurifier ® is a first-in-class medical device that targets the rapid elimination of life-threatening infectious disease and cancer glycopathogens from circulation.
Under the feasibility study protocol, Aethlon will enroll ten end stage renal disease (ESRD) patients who are infected with the Hepatitis C virus (HCV) to demonstrate the safety of Hemopurifier therapy. Successful completion of the feasibility study will set the stage for Aethlon to conduct pivotal studies required for market clearance to treat HCV and potentially other disease conditions.
Investorideas.com Newswire About Aethlon Medical (OTCQB: AEMD)
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT product pipeline includes the Aethlon Hemopurifier to address infectious disease and cancer, and a medical device being developed under a 5-year contract with DARPA to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About InvestorIdeas.com: Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech and medical technology stocks:
http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas has been compensated by AEMD for news release distribution and content publishing: three thousand per month effective June 2013 http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 or 212-822-8842
Source - www.Investorideas.com

Social Media Stock UMeWorld's (OTCQB:UMEWF) Reports Video Platform Now Exceeds 4.7 Million Unique Visitors

HONG KONG - August 2, 2013 (Investorideas.com newswire) Social Media Stock Alert: MeWorld Limited (OTCQB: UMEWF) is pleased to announce that UMeLook.com, an online video platform focused on bringing foreign video content to China, had 4.7 million unique visitors and over 20 million page views in July 2013. UMeLook.com has seen a significant increase in viewer traffic after having completed a total redesign and a renewed focus on the user experience just two months ago. Visitors now spend an average of more than nine minutes on UMeLook.com per visit. UMeLook.com has achieved a ranking of 5,169 in China and 42,040 globally according to Alexa.

"I am thrilled with the latest key performance indicators, especially because we have achieved them in just a few months. We are not so far from monetizing our video platform with pre-roll, post-roll and banner advertisements," said Michael Lee, President & CEO of UMeWorld Limited.
About UMeWorld
UMeWorld's mission is to facilitate the interaction between people -- "You" and "Me," through its digital platform. Currently, UMeWorld operates UMeLook (www.umelook.com), an online video platform focused on bringing foreign video content to China. UMeLook is deployed through a sophisticated CDN (Content Delivery Network) with broad coverage throughout mainland China, Hong Kong & Taiwan. UMeLook plans to be a source of foreign video content for the Chinese viewer across any Internet-enabled device in China. UMeWorld intends to focus its future operations on digital media and the digital education market.
Forward Looking Statement
Statements in this press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. We assume no obligation to publicly update or revise any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release, even if new information becomes available in the future. For a more detailed description of the risk and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission.
For more information, please contact:
UMeWorld Limited
E-mail: info@UMeWorld.com
Published at Investorideas.com – Big Ideas for Global Investors
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: UMEWF compensates Investorideas.com for news publication and syndication : two thousand per month
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

How Google (GOOG), AT&T (T) and Technology Companies are Opening up the World

Point Roberts, WA, New York, NY - August 2, 2013 (Investorideas.com newswire) Investorideas.com, providing global investing ideas in leading sectors including technology, issues a sector snapshot on developments and the market opportunity for language coding (all Unicode & all ASCII) technology and software.  With apps like the AT&T Translator ( NYSE:T ) Google’s Android (NASDAQ :GOOG), The Bible App in 400 languages, all are working on changing worldwide DIGITAL communications.
Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner
Google is looking at how to take digital languages to the next level, and then it’s just a matter of time before language will no longer have any barriers and business and individuals will be able to communicate with anyone, anywhere in any language. And as Google says: they will bring everyone to the Internet by 2020.
A pioneer in the sector, Dr. Philip Payne, founder of Linguist's Software Inc. http://www.linguistsoftware.com/ , started his company 30 years ago in Edmonds, WA not knowing the path to globalization that lay ahead. He grew his company to provide fonts and input from 200 to over 2000 languages over the last three decades, making it by far the largest linguistic software library of its kind.  Now this new (IP) is ten times larger (language/font/key-guide & tool set) than Adobe, who used to be the world leader.
Ken Kinkel, CEO of Mergers & Acquisitions ( www.CorpMA.com ) represents Dr. Payne’s exit strategy and retirement from Linguist's Software Inc. and understands the value of his language software to change the future of mobile and the internet communications.
"Google has said they will have everyone on the Internet by 2020. They are moving so fast that only companies with these 2000+ languages could have a chance to catch up to Google.  Maybe even beat them, to what is now looking like a monopoly for Google by 2020. That’s an astonishing prediction and if it’s true, then the company that owns these 2,000 plus languages will be a perfect position to capitalize on this astonishing achievement.  Being connected worldwide is one thing, but being able to communicate in practically every language of the world is quite another.  Our client’s product makes this possible.  Universal connectivity and now matched with the available in one’s own language - a perfect combination for the future of worldwide digital communications.
Other firms may even beat Google, to what is now looking like a worldwide monopoly for them by 2020.  By using their cell phone dominance (and 6.3 billion cell phones that exist today, according to the UN) they could skip past the huge infrastructure that Google is now building in fiber, and power worldwide. And use existing cell technology to take these languages to world dominance right now and well before Google’s dominance by 2020.
Previous article reference:
How do you say "Apple" in 2000 Languages?
Linguist's Software Blazes the Path to Globalization for Web and Mobile Devices with Fonts and Keyboard Input for 2000 Languages
http://www.investorideas.com/news/2013/technology/07151ep.asp
About InvestorIdeas.com: Big ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated for this article distribution http://www.investorideas.com/About/Disclaimer.asp
Source - www.Investorideas.com
Contact for more info on Linguist's Software, Inc.
Ken Kinkel CEO@CorpMA.com 1-855-559-0100 x11

Thursday, August 01, 2013

Investorideas.com Launches Sponsored Investment Content, a New Way to Reach Targeted Investors and Consumers in Leading Sectors

Point Roberts, WA, New York, NY - August 1, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, a global news source featuring investing ideas for independent investors, announces new sponsored content opportunities for stock and business news. The ad format creates a new way to reach a targeted and relevant investor or consumer audience.

The new sponsored content advertising program allows companies to insert content ads (an average of 800 characters) into the bottom of published content that has reached an audience through social media and syndication and has attracted relevant eyeballs.
This creates an opportunity for a smaller or competing company to place relevant content in an article, story or news release from a larger well- known brand or stock.
If a company does not have news of its own to publish for the week, this also creates an opportunity to tag other relevant news and reach an even larger potential audience with the right news source.
Investor Ideas publishes original investment research and news, global news and events, third party investment commentary from well- known and respected newsletter writers, as well as company news and press releases within leading sectors.
Content sponsorship includes investing ideas, trading alerts and stock news for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech ( 14 sectors in total ) trading on the TSX, OTC, NASDAQ, NYSE, ASX and major global stock exchanges.
Investorideas.com newswire is a news source on Google News, Linkedin.com/today as well as global syndication partners, blogs and social media.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks, gaming, homebuilder and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact us at 800-665-0411
More contact info and services info for Investor Ideas:
http://www.investorideas.com/Investors/Services.asp
Source - www.Investorideas.com

Stem Cell Stock Alert: BioRestorative Therapies (OTCBB: BRTX) Provides Company Updates with Shareholder Letter

JUPITER, Fla. - August 1, 2013 (Investorideas.com Newswire) BioRestorative Therapies Inc. ("BRT" or the "Company") (OTCQB: BRTX), a life sciences company focused on stem cell-based therapeutics, today announced the issuance of a shareholder letter by Chief Executive Officer, Mark Weinreb, providing an update to shareholders on the Company's progress.

The shareholders were advised as follows:
Over the past 12 months, BRT's substantial investment in research and development has allowed the Company to continue executing on its growth strategy. There have been many developments, both operationally and scientifically, that have positioned the Company well as a growing stem cell biotechnology company with a specific focus on cellular treatments and therapies for certain medical applications.
Below are some of the Company's accomplishments and activities over the past 12 months:
  • In the latter part of 2012, BRT appointed Wayne A. Marasco, M.D., Ph.D. as Chairman of its Scientific Advisory Board. Dr. Marasco currently serves as an Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute. He is head of Marasco Labs, an accomplished research laboratory at Dana-Farber Cancer Institute known for discovery and therapeutic human monoclonal antibody development and for constructing and validating various human-mouse chimeric models in the area of cancer, infectious disease immunotherapy, regenerative medicine and tissue engineering. Dr. Marasco is a Principal Faculty Member of the Harvard Stem Cell Institute and has extensive experience in the field of stem cells.
  • Late last year, the Company announced that its common stock had begun trading on the OTC Bulletin Board. The company went through a very thorough and diligent review process by FINRA to attain the Bulletin Board listing. The Bulletin Board trading platform allows for more potential investors interested in purchasing the Company's stock. The Company is extremely pleased to provide investors increased visibility and transparency that this regulated quotation service provides.
  • In late November, BRT launched its new website available at www.biorestorative.com. The new site highlights the Company as an innovator and pioneer in the adult stem cell industry. The Company's primary programs are highlighted in more detail on the website, along with rich imagery and information about therapies being developed.
  • At the start of 2013, the Company was invited to present at the Adipose Tissue Biology conference of the Keystone Symposia conference series. Chief Scientist and Vice President of Research and Development, Francisco Silva, presented the Company's research on "Human Metabolically Active Brown Adipose Tissue Derived Stem Cells." This research is a result of the scientific work the Company has been performing pursuant to its ThermoStem® Program, which is in the pre-clinical stage and which focuses on treatments for metabolic disorders (particularly focusing on Type 2 diabetes) and obesity and uses adult derived stem cells from brown adipose (fat) tissue stem cells.
  • On April 13th, Dr. Marasco spoke at the Second International Vatican Adult Stem Cell Conference: Regenerative Medicine -- A Fundamental Shift in Science and Culture. The event was held in Vatican City from April 11th to April 13th. Dr. Marasco spoke during the session entitled "Stem Cells, Cancer and Aging — A Search for Solutions." His talk was titled "What Questions Haven't Been Addressed with Respect to Stem Cells, Cancer and Aging?"
  • In April, the Company was invited to present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria. Mr. Silva presented the Company's research on Human Metabolically Active Brown Adipose Tissue Derived Stem Cells. This research is a result of the scientific work the Company has been performing pursuant to its ThermoStem® Program.
  • The Company hired ProActive Capital in mid-April to help increase awareness of the Company among the investment community. ProActive Capital is also helping to increase exposure through the use of social and digital media.
  • In mid April, the Company implemented a 1-for-50 reverse stock split which reduced its outstanding shares from 820,641,011 to 16,412,820. 94% of the shares voted were in favor of the proposal. The Company believes the reverse split will help attract a new base of shareholders as well as new institutional and retail support in the market.
  • In mid May, the Company signed an agreement with Dexterity, Inc., a product design and bioengineering firm, to further the development and production of its brtxDISC™ (Disc Implanted Stem Cells) stem cell therapy device. This device plays an integral role in delivering stem cells for its proprietary bulging/herniated disc therapy.
  • In May, the Company once again presented its investment thesis at the Marcum MicroCap Conference. To listen to the webcast, please visit http://wsw.com/webcast/marcum/brtx. The event hosted nearly 100 publicly traded companies with capitalizations under $500 million and attracted more than 1,000 people, including senior personnel from the presenting public companies, leading institutional investors, directors, bankers and service providers to the microcap marketplace.
  • At the end of May, the Company formally launched its "brtx-C Cosmetic" Program. The Company announced that it has developed a human cellular-derived extract that, per initial in vitro studies, when applied to skin cells, appears to cause a significant increase in collagen and fibronectin production (proteins that are essential for combating the aging of skin). The Company plans to conduct additional in vitro studies to better understand the extract's mechanism of action and human cellular activity and is actively seeking collaborations with other parties to commercialize the product.
  • In mid June, financial personality and founder of NBT Equities Research, Tobin Smith, interviewed CEO Mark Weinreb with regard to the Company's hybrid business model and what it is currently doing that will help change the biotechnology landscape. Click here for the full interview: http://direct.nbtequitiesresearch.com/video/nbt-biorestorative-1
  • In late June, the Company expanded its ThermoStem® Program by collecting 150 samples of human brown adipose tissue. This strengthens its R & D platform for the development of treatments for metabolic disorders and obesity. For the past year, through strategic collaboration and internal efforts, the Company has grown a large library of human brown fat stem cells. The compilation of a large number and variety of brown fat derived stem cells allows it to study and identify potential cell lines to be used in developing therapies.
  • In mid July, the Company was featured in the industry publication, "The Life Sciences Report." In the interview included in the report, CEO Mark Weinreb described how the Company's cell therapy process could possibly keep disc disease treatment out of the operating theater. Link to full interview: http://www.thelifesciencesreport.com/pub/na/15470
  • Since 2011, the Company has raised approximately $9 million, which has enabled it to achieve clear milestones as it continues to build momentum on its growth strategy.
"Based on these accomplishments, we are excited for what lies ahead in the near and long term," states CEO Mark Weinreb. "We continue to make speedy and efficient progress with our programs and look forward to further advancements regarding each of our exciting initiatives. I would like to thank all of our shareholders for their continued support. We will continue to work diligently to further execute our growth plan so that BioRestorative Therapies will be able to mature into a prominent life sciences company."
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. ("BRT"), www.biorestorative.com, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, designed for patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives:
  • brtxDISC™ Program (Disc Implanted Stem Cells), a non-surgical treatment for bulging and herniated discs that addresses the gap between non-invasive and invasive back procedures. This research is still in the non-clinical, investigational stage.
  • ThermoStem® Program, a treatment for metabolic disorders (diabetes, heart disease, etc.) and obesity using brown fat stem cells. Initial non-clinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body.
  • brtx-C Cosmetic Program, based on the development of a human cellular extract that, per initial in vitro studies, when applied to human skin cells, appears to cause an increase in the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. Potential cosmetic uses are being explored with third parties.
The Company also offers plant stem cell-based facial creams and beauty products under the Stem Pearls® brand at www.stempearls.com.
This press release and the interview contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
Investor Contact:
Adam Holdsworth
ProActive Capital
646.862.4607
adamh@proactivecapital.com
Media Contact:
Sandra Lee
ProActive Capital
646.862.4608
slee@proactivecapital.com
Disclaimer /Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk.
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: BioRestorative has compensated Investoridea for a six month news program ( five thousand ) to be published on Investorideas.com newswire and syndication and social media partners.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

China Social Media Stock Alert: UMeWorld's (OTCQB:UMEWF) Video Platform Surpasses 4.7 Million Unique Visitors and Continues to Attract Chinese Viewers

HONG KONG - August 1, 2013 (Investorideas.com newswire) MeWorld Limited (OTCQB: UMEWF) is pleased to announce that UMeLook.com, an online video platform focused on bringing foreign video content to China, had 4.7 million unique visitors and over 20 million page views in July 2013. UMeLook.com has seen a significant increase in viewer traffic after having completed a total redesign and a renewed focus on the user experience just two months ago. Visitors now spend an average of more than nine minutes on UMeLook.com per visit. UMeLook.com has achieved a ranking of 5,169 in China and 42,040 globally according to Alexa.

"I am thrilled with the latest key performance indicators, especially because we have achieved them in just a few months. We are not so far from monetizing our video platform with pre-roll, post-roll and banner advertisements," said Michael Lee, President & CEO of UMeWorld Limited.
About UMeWorld
UMeWorld's mission is to facilitate the interaction between people -- "You" and "Me," through its digital platform. Currently, UMeWorld operates UMeLook (www.umelook.com), an online video platform focused on bringing foreign video content to China. UMeLook is deployed through a sophisticated CDN (Content Delivery Network) with broad coverage throughout mainland China, Hong Kong & Taiwan. UMeLook plans to be a source of foreign video content for the Chinese viewer across any Internet-enabled device in China. UMeWorld intends to focus its future operations on digital media and the digital education market.
Forward Looking Statement
Statements in this press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. We assume no obligation to publicly update or revise any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release, even if new information becomes available in the future. For a more detailed description of the risk and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission.
For more information, please contact:
UMeWorld Limited
E-mail: info@UMeWorld.com
Published at Investorideas.com – Big Ideas for Global Investors
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: UMEWF compensates Investorideas.com for news publication and syndication : two thousand per month
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Wednesday, July 31, 2013

Solar Stock Trading Alert: XsunX, Inc. (OTCQB: XSNX) Closes up 32%

New York, NY, Point Roberts, WA - July 31, 2013 (Investorideas.com renewable energy newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including renewable energy stocks, issues a trading alert for solar stock, XsunX, Inc. (OTCQB: XSNX). The stock closed trading on Tuesday July 30 th at $0.0085, gaining 0.0021 or 32.81% on over 4.4 Million shares.

The company issued a shareholder update Tuesday discussing recent activity in the stock as well as a corporate update on the technology. See http://www.xsunx.com/news.php?nid=366
Worldwatch (www.worldwatch.org) also said on Tuesday that, “Global use of solar and wind energy continued to grow significantly in 2012. Solar power consumption increased by 58 percent, to 93 terrawatt-hours (TWh), and the use of wind power increased by 18 percent, to 521 TWh. Although hydropower remains the world's leading renewable energy, solar and wind continue to dominate investment in new renewable capacity and are quickly becoming the highest-profile renewable energy sources. “
Investorideas.com Newswire About XsunX (OTCQB: XSNX)
XsunX, Inc. is working to commercialize a new manufacturing process to produce low cost, high efficiency thin-film Copper Indium Gallium (di) Selenide (CIGS) thin film solar cells. Our patent-pending processing technology, which we call CIGSolar®, focuses on the mass production of thin-film CIGS solar cells utilizing a proprietary multi-area thermal deposition process to minimize processing defects to create highly uniform CIGS films. These cells match silicon solar cell dimensions and can be offered as a non-toxic, high-efficiency and lowest-cost alternative to the use of silicon solar cells. The company is offering licenses for the use of the CIGSolar® process technology, and plans to generate revenue through licensing fees and manufacturing royalties for the use of the CIGSolar® technology.
For more information please call XsunX at 888-797-4527, or visit the company's website at www.xsunx.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 14 online stock directories 24/7 – water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by XSNX for news distribution averaging 1500 per month
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 - Source – www.Investorideas.com

Tuesday, July 30, 2013

Investorideas.com - Agora Financial: "Rip, Mod, Make" The Manufacturing Revolution

Investorideas.com - Agora Financial: "Rip, Mod, Make" The Manufacturing Revolution

Chris Anderson, former Editor in Chief of Wired Shares Future of 3D Printing



3New York, NY, Point Roberts, WA - July 30, 2013 (www.investorideas.com newswire) Investorideas.com, an investor research portal featuring global investing ideas for independent investors continues its special feature on the Agora Financial Investment Symposium held last week in Vancouver at the Fairmont Vancouver.


Chris Anderson, former Editor in Chief of Wired, author of Makers: The New Industrial Revolution, and current CEO of 3D robotics and founder of DIY Drones, gave an awe inspiring presentation at the Agora Financial Symposium last Tuesday outlining the ideas presented in his book regarding "the new industrial revolution", which in Chris's view, is 3D printers.



Chris began by giving us a look back at the history of past industrial revolutions starting with the spinning jenny all the way up to the "information age" we currently live in. The next logical progression, according to Chris, will be the dawn of the manufacturing revolution, where as apple's "rip, mix, burn" slogan changed the online community not to mention the music, movie and book industries, the phrase "rip, mod, make" could drastically change the relationship between inventor and manufacturer, as well as consumer and manufacturer.



Chris goes on to show examples of how this idea is currently affecting the world around us and how technologies and programs are already in place to allow for the average person to jump into the role of inventor and manufacturer without ever having to leave their home.



3D Printers and CNC technology are no longer the experimental and costly machines they used to be and, as with all modern technology, continue to advance rapidly into a cheaper more effective product.
full article : http://www.investorideas.com/news/2013/main/07303.asp#


Friday, July 26, 2013

Investorideas.com - Agora Financial "A Tale of Two Americas" Conference Gives Investors a Radical and Brilliant Insight into Investing

Investorideas.com - Agora Financial "A Tale of Two Americas" Conference Gives Investors a Radical and Brilliant Insight into Investing

Agora Financial “A Tale of Two Americas “ Conference Gives Investors a Radical and Brilliant Insight into Investing




New York, NY- Point Roberts WA–July 26, 2013 – (www.investorideas.com newswire,) Investorideas.com, an investor research portal featuring global investing ideas for independent investors issues a special feature on the Agora Financial Investment Symposium held this week in Vancouver at the Fairmont Vancouver, closing up today at 4:00. For investors looking for unique opportunities in both private companies and publicly traded companies, this event entitled, A Tale of Two Americas- Seeking Opportunity at the Crossroads of Great Energy Revolution, Radical New Technologies and the Crushing Debt Crisis, does just that.



For investors tired of mainstream investment commentary from CNBC and Yahoo Finance, this conference featured exhibitors and speakers that are introducing ideas, services and technologies that are new, groundbreaking and sometimes controversial.



In terms of technology and ideas that most investors are not aware of, Chris Anderson, former editor of Wired, shared a vision of his company, 3D Robotics. In his presentation, The New Industrial Revolution, he talks about changing the face of manufacturing forever if 3d Printing is adopted into mainstream. 3D printing may be possible to change the way inventors and entrepreneurs bring new products to market in a very short time and in a cost effective manner. It truly takes the mantra of if you can think it you can create it to a whole new level.



Another example was a newly listed TSX agriculture stock, the first of its kind in the sector, Input Capital Corp (TSX: INP.V). Input is the world's first agriculture commodity streaming company. Using its innovative, proprietary agriculture streaming process, Input makes an upfront payment to the owner/operators of grain and oilseed farms in Western Canada in exchange for the purchase of a portion of their future production at a fixed price per tonne for the life of the streaming contract. This long-term working capital enables farmers to unlock the yield potential of their crops by optimizing their inputs and precision farming practices. Input currently has a focus on canola in Saskatchewan, Alberta and Manitoba. The company follows the model set in the mining industry by companies like Silver Wheaton, the largest precious metal streaming company in the world.



full article :http://www.investorideas.com/news/2013/main/07264.asp

Thursday, July 25, 2013

Stem Cell Stock Alert: BioRestorative Therapies (OTCBB: BRTX) CEO Mark Weinreb Interviewed by The Life Sciences Report

SAN FRANCISCO, CA - July 25, 2013 (Investorideas.com Newswire) "Millions of people suffer back pain caused by herniated and bulging disc disease. When conventional medical therapies fail, they often resort to surgery for relief, a costly and time-consuming solution for both patients and the medical system. In this interview with The Life Sciences Report, Mark Weinreb, president, CEO and chairman of BioRestorative Therapies Inc. (OTCQB: BRTX), describes how his company's cell therapy process could keep disc disease treatment out of the operating theater.

The Life Sciences Report: Mark, what disease indication are you exactly going after for patients suffering with back pain?
Mark Weinreb: We have developed a novel cellular therapy and therapeutic delivery device for the treatment of bulging and herniated disc disease. We believe we can effectively and safely treat patients using a nonsurgical, minimally invasive procedure that can be performed routinely in a physician's office. This technology could effectively bridge the gap between noninvasive and surgical back procedures. There are at least one million people, annually, in the U.S. who could benefit from this type of procedure with the promise of avoiding surgery. We elected to pursue this market because of the early success we have seen in several patients who have received this treatment.
TLSR: Can you very briefly describe the technology?"
Continue reading this interview with Mark Weinreb: "BioRestorative Therapies Inc. Develops Plug-and-Play Therapy for Bulging and Herniated Disc Disease."
Read more about cell therapy and BioRestorative Therapies Inc. in The Life Sciences Report's in-depth interview with Jason Kolbert of Maxim Group: "Is Cell Therapy the 'Future of Medicine'?"
About Streetwise Reports - The Life Sciences Report
Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
Contact:
Streetwise Reports, LLC - The Life Sciences Report
Brandon Fung
Tel: 707-981-8107
Disclaimer /Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk.
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: BioRestorative has compensated Investoridea for a six month news program ( five thousand ) to be published on Investorideas.com newswire and syndication and social media partners.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Solar Industry to grow to $155 billion in 2018; U.S. Photovoltaic Manufacturing Consortium Aims to help make CIGS thin films a significant part of that solar success

Point Roberts, WA - July 25, 2013 (Investorideas.com renewable energy stocks newswire) Investorideas.com, an investor research portal specializing in investing ideas in leading sectors including renewable energy stocks, reports on the future of the solar sector and in particular, CIGS solar and the related solar stocks.

Lux Research says the solar photovoltaic (PV) market is poised to rise from the ashes of its 2011 crisis to grow to $155 billion in 2018, as market forces engineer a turnaround to a healthy 10.5% compound annual growth rate (CAGR.
They went on to say, "In the most likely scenario, the PV market will grow at a modest clip to 35 GW in 2013 before rapidly ramping up to 61.7 GW in 2018."
The U.S. Photovoltaic Manufacturing Consortium (PVMC) recently said in a press release, "Photovoltaics and especially thin-film PV are again at a tipping point," said Larry Kazmerski, co-chair of the U.S. CIGS PV Roadmap. "We want PV to be a substantial part of the world's energy portfolio and our efforts with this roadmap are aimed to help make CIGS thin films a significant part of that solar success."
CIGS solar stocks to watch include XsunX , Inc. (OTCQB: XSNX) , Ascent Solar Technologies, Inc. (NASDAQ:ASTI), Solar Frontier subsidiary of Showa Shell Sekiyu K.K. (TYO: 5002) and TSMC Solar, a wholly-owned subsidiary of Taiwan Semiconductor Manufacturing, Inc. (NYSE:TSM).
XsunX , Inc. (OTCQB: XSNX) closed up over 21% on just over 4 Million shares as of the close on Wednesday, gaining some of the ground it had lost in recent sessions. XsunX says its CIGSolar technology focuses on the mass production of thin-film CIGS solar cells utilizing a proprietary multi-area thermal deposition process to minimize processing defects to create highly uniform CIGS films. The manufacturing systems are modular and represent a new breed of CIGS manufacturing technology that can be deployed in various production configurations to produce CIGSolar cells. The potential impact and opportunity is to offer commercially viable replacements to existing incumbent poly-crystalline silicon technology, lowering the overall cost of PV energy.
Investorideas.com Newswire TSMC Solar said this week that its new target for CIGS module conversion efficiency is now set for 17 percent and utility expansion of 50 percent by 2014. In June the company reported confirmation by TUV SUD that its latest commercial-sized (1.09 m2) CIGS champion module has achieved 15.7% module total area efficiency. The new champion module improves on TSMC Solar's previous 15.1% world record set in January this year. The module was produced using the current manufacturing equipment and materials at the company's manufacturing facility in Taichung, Taiwan. The stock moved up on the day of the new targets announced.
Ascent Solar Technologies, Inc. (NASDAQ:ASTI) said earlier this week it will debut the newest additions to its EnerPlex KickrTM Series as well as introduce an exciting new line of EnerPlexTM products to be showcased at the Outdoor Retailer Summer show in Salt Lake City July 31st through August 3rd. Small enough to be attached to a belt loop yet powerful enough to make sure devices always have a charge, the Kickr line of personal solar chargers is uniquely enabled by the rugged, lightweight and flexible form factor of Ascent's CIGS solar cells.
The stock has made some big moves just over the last month and closed up marginally again on the close of Wednesday's session.
Investorideas.com Newswire Among Lux Research findings:
U.S., China, Japan, and India will take over where Germany and Italy left off. With an 18% CAGR to 10.8 GW of installations in 2018, the United States will emerge the world's second-largest market. But China will leapfrog it, growing over 15% annually to 12.4 GW in 2018.
Utility-scale installations to grow the fastest; commercial the largest. Utility-scale solar, the smallest segment in 2012 at 8.6 GW, will grow the fastest to 19.9 GW in 2018 as developing markets turn to PV. Globally, commercial applications reign supreme as markets like the U.S. and Japan move to large rooftop installations.
Opportunities abound for cheap IP. Struggling start-ups present opportunities to acquire intellectual property at record low prices. A case in point: Hanergy acquired Miasolé - which in 2012 announced the leading CIGS module efficiency at 15.5% - for only $30 million after investors had pumped $500 million into the firm.
About InvestorIdeas.com: Big ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free solar stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by XSNX for news distribution averaging fifteen hundred per month
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar
800-665-0411 - Source - www.Investorideas.com

Investorideas.com Q&A with Juan Carlos Gonzalez, Foreign Investment Vice-President at Proexport Colombia

Point Roberts WA, New York, NY - July 25, 2013 (www.investorideas.com newswire) Investorideas.com, an investor research portal specializing in sector research for global investors issues an exclusive interview with Juan Carlos Gonzalez, the Foreign Investment Vice-President at Proexport, Colombia, a National Agency for the promotion of FDI, non-traditional exports and international tourism. The interview gives insight into the past, present and future relationship between Colombia and Canada and how the mindset of a country can change its destiny.

With a population of 47 Million people and a demographic of 55% being younger than 30, his closing comment was possibly the most significant in the interview.
When asked what has changed the most in Colombia over the past ten years and what the biggest driving force is, he told Investorideas.com that it was a change of mindset. “Colombians started to believe that their future would be better than their past . Ten years ago a young person's biggest goal was to leave Colombia, now it is to start a business. “
If Colombia could bottle that optimism and entrepreneurial spirit, it could possibly become its biggest export .
The following is a summary of the discussion that took place July 19 th.
Q: Investorideas.com
Before we discuss the future of the trade relationship between Canada and Colombia, can you give us a glimpse of what has happened since the Canada/ Colombia Free Trade Agreement became effective in 2011?
A: Juan Carlos Gonzalez, Foreign Investment Vice-President at Proexport Colombia
Canada was the first G7 country to open up new markets in Colombia . It was a big leap not just for Colombia but also for neighboring markets. One of the biggest impacts was the growth in tourism and how it opened up the eyes of Canadians to a new Colombia.
Over the past two years both countries have learned about each others markets. Proexport has actively promoted the opportunities that exist between the two countries and has expanded its presence in Canada, with offices in Vancouver, Toronto and Montreal .
More Colombian countries are exporting to Canada, but the true picture is not all reflected in just the numbers. It's more about the mutual education of opportunities. Colombians did not know a lot about Canada prior to the agreement and Canadians needed to learn more about the potential role of Colombia in its future . One of the key points we try to educate foreign business on is that the country is split into very different regions that each represent their own unique opportunities .
The FTA created a venue that allows for a flow of business but education is essential to show business on both sides how to take advantage of it.
We are now seeing opportunities expand beyond traditional markets of oil and gas, mining and coffee.
Q: Investorideas.com
How much of a role does Canada play in Colombia's economy ?
A: Juan Carlos Gonzalez, Foreign Investment Vice-President at Proexport Colombia
Since August 2011- May 2013, a significant number of Colombian companies exported to Canada for the first time . Stats show 140 new Colombian companies have exported their products to Canada with 66 new products
There has been a lot of growth in non traditional exports including flowers, textiles, cosmetics and auto parts.
According to Stats Canada , Colombian exports to Canada reached US$ 218, 5 million between January and April 2013, and the subsectors with greater participation include those that have contributed traditionally to trade between the two countries. Coal and Petroleum (39%), Coffee (23%), Flowers (14%), Banana and other fruits (10%). These 4 represent 85% of Colombian exports to Canada.
When asked about progress in global markets, Juan Carlos Gonzalez noted that Colombia is seeing record growth. Ten years ago global exports were 11 Billion and last year it rose to 60 Billion. Another significant indicator is the inflow of foreign investment over the past 10 years. Colombia is ranked 3 rd after Chile and Brazil for investment into South American countries. In 2012, Colombia received over $15 billion of Foreign Direct Investment.
Tourism is also a growing market, expanding from just over 300,000 visitors then years ago to over 3 Million now.
Q: Investorideas.com
Can you discuss Colombia's investor protection policy and its global ranking ?
A: Juan Carlos Gonzalez, Foreign Investment Vice-President at Proexport Colombia
Colombia has been very stable and has not defaulted on its debt. Colombia takes all investment very seriously and is responsible to its investors. According to the World Bank, its global ranking we are number 6, while Canada is number 4 in the world. Their ranking measures the strength of minority shareholder protections against misuse of corporate assets by directors for their personal gain.
The World Bank also notes that Colombia is the third most business-friendly and the leading reforming country in Latin America.
Q: Investorideas.com
How tax friendly is Colombia to the business community?
A: Juan Carlos Gonzalez, Foreign Investment Vice-President at Proexport Colombia
The corporate tax rate is 33% but Colombia is very proactive and has created free trade regions with tax rates of 15%.
As part of the government's effort to create jobs, there are also incentives to start business in certain sectors. Additionally they have lowered payroll taxes based on certain tax reforms passed last year. Payroll taxes have been lowered from 50% to 25- 30%.
Q: Investorideas.com
What industry sectors are untapped for new business between Colombia and Canada?
A: Juan Carlos Gonzalez, Foreign Investment Vice-President at Proexport Colombia
Colombia has a sizeable growing market of over 47 Million people, currently the second largest Spanish speaking country in the world after Mexico.
There is a growing dynamic middle class economy that creates opportunity on many fronts, and in particular consumer products. Colombia is seeing a lot of retail and consumer markets opening up. Not only do the companies get to serve Colombia consumers, but also surrounding countries.
Some examples of untapped opportunities include service providers for the oil and gas and mining sectors. There is a great opportunity to serve the resource industry and identify areas where they don't have technology to meet the needs; for example, environmental services or pipeline services.
Another key area to look at is the services sector. There is a growing population and talent pool to capitalize on. Many companies are coming into Colombia and setting up customer service centers.
Canada 's animation industry has come to Colombia looking for expertise in the digital sector as well as telecom companies have set up operations in Colombia to serve Latin American markets.
Colombia also has a gap in infrastructure, including transportation, housing, construction and the materials sector.
There is also a growing market for cleantech and renewable energy technologies. Foreign companies have come into Colombia with waste management and waste to energy technologies.
Juan Carlos also made clear that small and medium businesses looking to start operations or trade with Colombia should contact Proexport and make use of their resources. They can help business create a tailor made plan specific to their sector. Colombia is looking for innovation and partners and small business is always known to bring innovation to the forefront.
The Colombian government is making it easier for new business to get Visas, to encourage and promote innovation and R&D.
So for business leaders looking for new opportunities and a new frontier - all roads lead to Colombia …
Interview by D. Van Zant Investorideas.com
Bio /Juan Carlos Gonzalez Foreign Investment Vice-President at Proexport
He has been in charge of designing and implementing Colombia´s foreign investment promotion strategy as the country has become one of the top
recipients of FDI in Latin America. Proexport was ranked by the World Bank (FIAS) in 2009 among the top 25 Investment Promotion Agencies in the world
out of 213 agencies assessed by the quality of the information and services provided to prospective investors. Between January 2009 and June
2010, 98 new projects with expected investments of over US$1.5 billion were initiated in Colombia by foreign investors supported by Proexport.
Previously, Mr. Gonzalez was Economic and Trade Attaché at the Colombian Embassy in Japan, Vice-President at the Invest in Colombia Corporation
-COINVERTIR- , Director for International Affairs at the National Directorate of Taxes and Customs, and Adviser to the Minister of Foreign Affairs.
Mr. Gonzalez did his undergraduate studies in Economics at Universidad de los Andes ( Bogota), Lewis and Clark College ( Portland, Oregon) and Hokusei
Gakuen University ( Sapporo, Japan). He holds a Master´s degree in International Studies from the University of Washington ( Seattle), and an MBA from the Melbourne Business School ( Australia).
He is fluent in English and Japanese and has working level proficiency in French and Portuguese.
Investorideas.com Newswire Proexport Colombia
http://www.proexport.com.co/en
Proexport provides business opportunities, clear information on requirements, strategies for expanding services and goods at an international level, participation in business fairs and assistance by experts for investors, exporters, and professionals that wish to come closer to their dreams.
About InvestorIdeas.com:
www.InvestorIdeas.com is a global leader in investor sector research, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy and beverage stocks.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities.
800-665-0411 - Source - www.Investorideas.com